Association between marijuana exposure and pulmonary function over 20 years

JAMA

Volumn 307, Issue 2, 2012, Pages 173-181

  Pletcher, Mark J ^a   Vittinghoff, Eric ^a   Kalhan, Ravi ^b   Richman, Joshua ^c,e   Safford, Monika ^d   Sidney, Stephen ^f   Lin, Feng ^a   Kertesz, Stefan ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c University of Alabama at Birmingham   (United States)

^d and Clinical Center   (United States)

^e BIRMINGHAM VA MEDICAL CENTER   (United States)

^f DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; TOBACCO SMOKE;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SMOKING;

EID: 84855716428     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1961     Document Type: Article

References (36)

1. Kamholz SL. Pulmonary and cardiovascular consequences of smoking. Med Clin North Am. 2004; 88(6):1415-1430. (Pubitemid 39298736)
2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(9434):613-620. (Pubitemid 39094180)
3. Number of deaths from each cause, by 10-year age groups, race, and sex: United States, 2005. Centers for Disease Control and Prevention National Vital Statistics Web site. http://205.207.175.93/VitalStats/TableViewer/tableView. aspx?ReportId=26044. Accessed November 30, 2011.
4. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6(4): e1000058.
5. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238-1245. (Pubitemid 38541668)
6. Novotny M, Merli F, Weisler D, Fencl M, Saeed T. Fractionation and capillary gas chromatographic-mass spectrometric characterization of the neutral components in marijuana and tobacco smoke condensates. J Chromatogr A. 1982;238(1):141-150. (Pubitemid 12041831)
7. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112(2):319-326. (Pubitemid 27349419)
8. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998;90(16):1198-1205. (Pubitemid 28407085)
9. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers.AmJ Respir Crit Care Med. 1998;157(3, pt 1):928-937.
10. Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol. 2002; 42(11)(suppl):71S-81S. (Pubitemid 35205049)
11. Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007; 167(3):221-228.
12. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698): 1383-1391.
13. Tashkin DP. Does cannabis use predispose to chronic airflow obstruction? Eur Respir J. 2010; 35(1):3-5.
14. Results from the 2008 National Survey on Drug Use and Health: National Findings. HHS Publication SMA 09-4434. Substance Abuse and Mental Health Services Administration Web site. http://www.oas.samhsa.gov/NSDUH/2k8NSDUH/ 2k8results.cfm. 2009. Accessed November 30, 2011.
15. Joy JE, Watson SJ, Benson JA, eds. Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academies Press; 1999.
16. Cannabis and cannabinoids. National Cancer Institute Web site. http://www.cancer.gov/cancertopics/pdq/cam/cannabis/healthprofessional. 2011. Accessed November 30, 2011.
17. Hughes GH, Cutter GR, Donahue R, et al. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) study. Control Clin Trials. 1987;8(4)(suppl):68S-73S.
18. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105-1116. (Pubitemid 19039041)
19. Wagenknecht LE, Burke GL, Perkins LL, Haley NJ, Friedman GD. Misclassification of smoking status in the CARDIA study: a comparison of self-reportwith serum cotinine levels. Am J Public Health. 1992; 82(1):33-36.
20. Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42-47.
21. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
22. Miller MR, Hankinson J, Brusasco V, et al ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. (Pubitemid 41079078)
23. Kelly FJ, Fussell JC. Air pollution and airway disease. Clin Exp Allergy. 2011;41(8):1059-1071.
24. Air quality monitoring information: air quality statistics by city, 2009. US Environmental Protection Agency Web site. http://www.epa.gov/airtrends/ factbook.html. Accessed November 30, 2011.
25. Marrie RA, Dawson NV, Garland A. Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. J Clin Epidemiol. 2009;62(5):511-517, e1.
26. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA. 1994; 272(19):1497-1505.
27. Sherman MP, Roth MD, Gong H Jr, Tashkin DP. Marijuana smoking, pulmonary function, and lung macrophage oxidant release. Pharmacol Biochem Behav. 1991;40(3):663-669.
28. Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed). 1987;295(6612): 1516-1518. (Pubitemid 18009749)
29. Sherrill DL, Krzyzanowski M, Bloom JW, Lebowitz MD. Respiratory effects of non-tobacco cigarettes: a longitudinal study in general population. Int J Epidemiol. 1991;20(1):132-137.
30. Taylor DR, Poulton R, Moffitt TE, Ramankutty P, Sears MR. The respiratory effects of cannabis dependence in young adults. Addiction. 2000;95(11): 1669-1677.
31. Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med. 2005;20(1): 33-37. (Pubitemid 40271036)
32. Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62(12):1058-1063. (Pubitemid 350206197)
33. Tashkin DP, Calvarese BM, Simmons MS, Shapiro BJ. Respiratory status of seventy-four habitual marijuana smokers. Chest. 1980;78(5):699-706. (Pubitemid 11238666)
34. Tashkin DP, Simmons MS, Chang P, Liu H, Coulson AH. Effects of smoked substance abuse on nonspecific airway hyperresponsiveness. Am Rev Respir Dis. 1993;147(1):97-103. (Pubitemid 23025923)
35. Tashkin DP, Simmons MS, Sherrill DL, Coulson AH. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am J Respir Crit Care Med. 1997;155(1):141-148. (Pubitemid 27053155)
36. Tashkin DP, Coulson AH, Clark VA, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987;135(1):209-216. (Pubitemid 17223915)